Stay updated with breaking news from Sciences Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DekaBank Deutsche Girozentrale lowered its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 8.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 44,556 shares of the medical research company’s stock after selling 3,909 shares during the quarter. DekaBank Deutsche […]
Should You Buy or Sell Exact Sciences Stock? Get The Latest EXAS Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) shares were up 4.3% during mid-day trading on Wednesday . The company traded as high as $68.45 and last traded at $68.24. Approximately 1,059,655 shares were traded during mid-day trading, a decline of 55% from the average daily volume of 2,356,972 shares. The stock had previously closed at […]
Resources Investment Advisors LLC. lifted its position in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 1.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 100,193 shares of the medical research company’s stock after purchasing an additional 1,023 shares […]
Empire Life Investments Inc. cut its position in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 1.1% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 157,000 shares of the medical research company’s stock after selling 1,728 shares during the period. Empire Life Investments Inc.’s holdings in Exact Sciences were worth $7,773,000 at the […]